Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Peptide Therapeutics Market Trends and Global Forecasts to 2040 - Investments Exceeding $7 Billion from Public and Private Sectors Reflect Burgeoning Interest and Potential Returns

globenewswire.com
APLS Mentioned as a prominent player in the peptide therapeutics market, indicating its involvement in a growing industry. BLRX Listed as a prominent player in the peptide therapeutics market, suggesting its participation in a growing sector. LLY NVO Identified as a prominent player in the peptide therapeutics market, indicating its role in a growing industry. TAK Named as a prominent player in the peptide therapeutics market, suggesting its involvement in a growing sector.

Dublin, Jan. 12, 2026 (GLOBE NEWSWIRE) -- The "Peptide Therapeutics Market: Industry Trends and Global Forecasts, Till 2040 - Distribution by Type of Peptide, Route of Administration, Key Therapeutic Area and Geographical Regions" has been added to ResearchAndMarkets.com's offering.

The peptide therapeutics market is projected to expand from USD 84.2 billion to USD 162.4 billion by 2035, registering a CAGR of 6.8% during this period. Peptide therapeutics, developed from polypeptides, address various illnesses and include treatments for metabolic diseases, cancer, and hormonal disorders.

Driven by increasing occurrences of chronic conditions like diabetes, cancer, and autoimmune disorders, the demand for peptide therapies has surged. FDA-approved peptide therapeutics, such as Tirzepatide (Mounjaro) and Lutetium Lu-177 vipivotide tetraxetan (Pluvicto), highlight the market's growth potential. Pharmaceutical companies are focusing on innovative drug conjugates to tackle a broad spectrum of diseases.

The report outlines critical insights into the peptide therapeutics market's current state and future opportunities:

The peptide therapeutics market is segmented into key areas:

Prominent players in the peptide therapeutics market include Apellis Pharmaceuticals, BioLineRx, Eli Lilly, Novo Nordisk, Takeda, and Zealand Pharma.

Key research areas explored in the report encompass market sizing, pipeline analysis, company profiles, and big pharma initiatives. The report addresses numerous critical questions and provides robust data supporting strategic decisions.

Purchase this report to harness detailed market analyses, understand competitive dynamics, and leverage insights for future growth. Additional benefits include Analytics Packs, free content customization, and report walkthrough sessions with the research team.

Key Attributes

A selection of companies mentioned in this report includes, but is not limited to:

For more information about this report visit https://www.researchandmarkets.com/r/qwndtg

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment